The Effect of Systemic Parameters and Baseline Characteristics in Short-Term Response Analysis with Intravitreal Ranibizumab in Treatment-Naive Patients with Neovascular Age-Related Macular Degeneration.

Autor: García-Quintanilla L; Pharmacy Department, University Clinical Hospital of Santiago de Compostela (SERGAS), 15706 Santiago de Compostela, Spain.; Clinical Pharmacology Group, Health Research Institute of Santiago de Compostela (IDIS), 15706 Santiago de Compostela, Spain.; Pharmacology, Pharmacy and Pharmaceutical Technology Department, Faculty of Pharmacy, University of Santiago de Compostela (USC), 15782 Santiago de Compostela, Spain., Almuiña-Varela P; Clinical Pharmacology Group, Health Research Institute of Santiago de Compostela (IDIS), 15706 Santiago de Compostela, Spain.; Ophthalmology Department, University Clinical Hospital of Santiago de Compostela (SERGAS), 15706 Santiago de Compostela, Spain., Rodríguez-Cid MJ; Ophthalmology Department, University Clinical Hospital of Santiago de Compostela (SERGAS), 15706 Santiago de Compostela, Spain., Gil-Martínez M; Ophthalmology Department, University Clinical Hospital of Santiago de Compostela (SERGAS), 15706 Santiago de Compostela, Spain., Abraldes MJ; Ophthalmology Department, University Clinical Hospital of Santiago de Compostela (SERGAS), 15706 Santiago de Compostela, Spain.; Instituto Oftalmológico Gómez-Ulla, 15706 Santiago de Compostela, Spain.; Department of Surgery, University of Santiago de Compostela, 15782 Santiago de Compostela, Spain., Gómez-Ulla F; Instituto Oftalmológico Gómez-Ulla, 15706 Santiago de Compostela, Spain., González-Barcia M; Pharmacy Department, University Clinical Hospital of Santiago de Compostela (SERGAS), 15706 Santiago de Compostela, Spain.; Clinical Pharmacology Group, Health Research Institute of Santiago de Compostela (IDIS), 15706 Santiago de Compostela, Spain., Mondelo-García C; Pharmacy Department, University Clinical Hospital of Santiago de Compostela (SERGAS), 15706 Santiago de Compostela, Spain.; Clinical Pharmacology Group, Health Research Institute of Santiago de Compostela (IDIS), 15706 Santiago de Compostela, Spain., Estany-Gestal A; FIDIS-Unidad de Epidemiología e Investigación Clínica, 15706 Santiago de Compostela, Spain., Otero-Espinar FJ; Pharmacology, Pharmacy and Pharmaceutical Technology Department, Faculty of Pharmacy, University of Santiago de Compostela (USC), 15782 Santiago de Compostela, Spain., Fernández-Rodríguez M; Ophthalmology Department, University Clinical Hospital of Santiago de Compostela (SERGAS), 15706 Santiago de Compostela, Spain.; Instituto Oftalmológico Gómez-Ulla, 15706 Santiago de Compostela, Spain.; Department of Surgery, University of Santiago de Compostela, 15782 Santiago de Compostela, Spain., Fernández-Ferreiro A; Pharmacy Department, University Clinical Hospital of Santiago de Compostela (SERGAS), 15706 Santiago de Compostela, Spain.; Clinical Pharmacology Group, Health Research Institute of Santiago de Compostela (IDIS), 15706 Santiago de Compostela, Spain.

Publikováno v: Pharmaceutics [Pharmaceutics] 2024 Jan 13; Vol. 16 (1). Date of Electronic Publication: 2024 Jan 13.

The role of retinal fluid location in atrophy and fibrosis evolution of patients with neovascular age-related macular degeneration long-term treated in real world.

Autor: Llorente-González S; Department of Ophthalmology, Clínica Universidad de Navarra, Madrid, Spain.; Retinal Pathologies and New Therapies Group, Experimental Ophthalmology Laboratory, Department of Ophthalmology, Clínica Universidad de Navarra, Pamplona, Spain.; Thematic Network of Cooperative Health Research in Eye Diseases (Oftared), Health Institute Carlos III, Department of Ophthalmology, Clínica Universidad de Navarra, Pamplona, Spain., Hernandez M; Retinal Pathologies and New Therapies Group, Experimental Ophthalmology Laboratory, Department of Ophthalmology, Clínica Universidad de Navarra, Pamplona, Spain.; Thematic Network of Cooperative Health Research in Eye Diseases (Oftared), Health Institute Carlos III, Department of Ophthalmology, Clínica Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research, IdiSNA, Pamplona, Spain., González-Zamora J; Department of Ophthalmology, Clínica Universidad de Navarra, Pamplona, Spain., Bilbao-Malavé V; Department of Ophthalmology, Clínica Universidad de Navarra, Madrid, Spain.; Department of Ophthalmology, Clínica Universidad de Navarra, Pamplona, Spain., Fernández-Robredo P; Retinal Pathologies and New Therapies Group, Experimental Ophthalmology Laboratory, Department of Ophthalmology, Clínica Universidad de Navarra, Pamplona, Spain.; Thematic Network of Cooperative Health Research in Eye Diseases (Oftared), Health Institute Carlos III, Department of Ophthalmology, Clínica Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research, IdiSNA, Pamplona, Spain., Saenz-de-Viteri M; Retinal Pathologies and New Therapies Group, Experimental Ophthalmology Laboratory, Department of Ophthalmology, Clínica Universidad de Navarra, Pamplona, Spain.; Thematic Network of Cooperative Health Research in Eye Diseases (Oftared), Health Institute Carlos III, Department of Ophthalmology, Clínica Universidad de Navarra, Pamplona, Spain.; Department of Ophthalmology, Clínica Universidad de Navarra, Pamplona, Spain., Barrio-Barrio J; Thematic Network of Cooperative Health Research in Eye Diseases (Oftared), Health Institute Carlos III, Department of Ophthalmology, Clínica Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research, IdiSNA, Pamplona, Spain.; Department of Ophthalmology, Clínica Universidad de Navarra, Pamplona, Spain., Rodríguez-Cid MJ; Complexo Hospitalario Universitario de Santiago, Santiago de Compostela, Spain., Donate J; Thematic Network of Cooperative Health Research in Eye Diseases (Oftared), Health Institute Carlos III, Department of Ophthalmology, Clínica Universidad de Navarra, Pamplona, Spain.; Hospital Clínico San Carlos, Madrid, Spain., Ascaso FJ; Department of Ophthalmology, Hospital Clínico Universitario Lozano Blesa and Instituto de Investigación Sanitaria de Aragón (IIS Aragón), Zaragoza, Spain., Gómez-Ramírez AM; Hospital General Universitario Reina Sofía de Murcia, Murcia, Spain., Araiz J; Thematic Network of Cooperative Health Research in Eye Diseases (Oftared), Health Institute Carlos III, Department of Ophthalmology, Clínica Universidad de Navarra, Pamplona, Spain.; Hospital San Eloy, Bilbao, Spain., Armadá F; Hospital Universitario La Paz, Madrid, Spain., Ruiz-Moreno Ó; Hospital Universitario Miguel Servet, IIS Aragón and Grupo de Investigación e Innovación Miguel Servet Oftalmología (GIMSO), Zaragoza, Spain., Recalde S; Retinal Pathologies and New Therapies Group, Experimental Ophthalmology Laboratory, Department of Ophthalmology, Clínica Universidad de Navarra, Pamplona, Spain.; Thematic Network of Cooperative Health Research in Eye Diseases (Oftared), Health Institute Carlos III, Department of Ophthalmology, Clínica Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research, IdiSNA, Pamplona, Spain., García-Layana A; Retinal Pathologies and New Therapies Group, Experimental Ophthalmology Laboratory, Department of Ophthalmology, Clínica Universidad de Navarra, Pamplona, Spain.; Thematic Network of Cooperative Health Research in Eye Diseases (Oftared), Health Institute Carlos III, Department of Ophthalmology, Clínica Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research, IdiSNA, Pamplona, Spain.; Department of Ophthalmology, Clínica Universidad de Navarra, Pamplona, Spain.

Publikováno v: Acta ophthalmologica [Acta Ophthalmol] 2022 Mar; Vol. 100 (2), pp. e521-e531. Date of Electronic Publication: 2021 Jun 04.

Clinical features, management and outcomes of patients with sterile endophthalmitis associated with intravitreal injection of antivascular endothelial growth factor.

Autor: Gil-Martínez M; Servicio de Oftalmología, Hospital de Conxo, Xerencia de Xestión Integrada de Santiago de Compostela, SERGAS, Santiago de Compostela, La Coruña, España; Instituto Oftalmológico Gómez-Ulla, Santiago de Compostela, La Coruña, España., Rodríguez-Cid MJ; Servicio de Oftalmología, Hospital de Conxo, Xerencia de Xestión Integrada de Santiago de Compostela, SERGAS, Santiago de Compostela, La Coruña, España., Fenández-Rodríguez MI; Servicio de Oftalmología, Hospital de Conxo, Xerencia de Xestión Integrada de Santiago de Compostela, SERGAS, Santiago de Compostela, La Coruña, España; Instituto Oftalmológico Gómez-Ulla, Santiago de Compostela, La Coruña, España., Blanco-Teijero MJ; Servicio de Oftalmología, Hospital de Conxo, Xerencia de Xestión Integrada de Santiago de Compostela, SERGAS, Santiago de Compostela, La Coruña, España., Abraldes MJ; Servicio de Oftalmología, Hospital de Conxo, Xerencia de Xestión Integrada de Santiago de Compostela, SERGAS, Santiago de Compostela, La Coruña, España; Instituto Oftalmológico Gómez-Ulla, Santiago de Compostela, La Coruña, España., Bandín Vilar E; Servicio de Farmacia, Xerencia de Xestión Integrada de Santiago de Compostela, SERGAS, Santiago de Compostela, La Coruña, España; Grupo de Farmacología, Instituto de Investigación Sanitaria (IDIS), Santiago de Compostela, La Coruña, España., Zarra-Ferro I; Servicio de Farmacia, Xerencia de Xestión Integrada de Santiago de Compostela, SERGAS, Santiago de Compostela, La Coruña, España; Grupo de Farmacología, Instituto de Investigación Sanitaria (IDIS), Santiago de Compostela, La Coruña, España., González-Barcia M; Servicio de Farmacia, Xerencia de Xestión Integrada de Santiago de Compostela, SERGAS, Santiago de Compostela, La Coruña, España; Grupo de Farmacología, Instituto de Investigación Sanitaria (IDIS), Santiago de Compostela, La Coruña, España., Gómez-Ulla F; Instituto Oftalmológico Gómez-Ulla, Santiago de Compostela, La Coruña, España., Fernández-Ferreiro A; Servicio de Farmacia, Xerencia de Xestión Integrada de Santiago de Compostela, SERGAS, Santiago de Compostela, La Coruña, España; Grupo de Farmacología, Instituto de Investigación Sanitaria (IDIS), Santiago de Compostela, La Coruña, España. Electronic address: anxordes@gmail.com.

Publikováno v: Archivos de la Sociedad Espanola de Oftalmologia [Arch Soc Esp Oftalmol (Engl Ed)] 2020 May; Vol. 95 (5), pp. 211-216. Date of Electronic Publication: 2020 Mar 08.

ULTRASONOGRAPHIC FINDINGS IN THE VITREOUS OF PATIENTS WITH AGE-RELATED MACULAR DEGENERATION TREATED WITH INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR INJECTIONS.

Autor: Mato-Gondelle T; Department of Ophthalmology, University Hospital of Santiago de Compostela, Santiago de Compostela, Spain., Bande MF, Paniagua L, Rodríguez-Cid MJ, Abraldes M, Fernández M, Blanco-Teijeiro MJ, Piñeiro A

Publikováno v: Retina (Philadelphia, Pa.) [Retina] 2018 Oct; Vol. 38 (10), pp. 1962-1967.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.